Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 466,818 shares at $32.29 ($15.4M) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Seasonal sale ($15.4M) by President & CEO — this insider has traded VKTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.29 | 132,454 | $4.3M | 27.8% |
| 2 | $32.29 | 132,454 | $4.3M | 27.8% |
| 3 | $33.38 | 53,279 | $1.8M | 11.6% |
| 4 | $33.38 | 53,279 | $1.8M | 11.6% |
| 5 | $34.22 | 41,276 | $1.4M | 9.2% |
| 6 | $34.22 | 41,276 |
| $1.4M |
| 9.2% |
| 7 | $35.07 | 6,400 | $224K | 1.5% |
| 8 | $35.07 | 6,400 | $224K | 1.5% |
| Total | $32.96 avg | 466,818 | $15.4M | 100% |
| Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |
| VKTX | SELL | 2024-09-20 | $30.6M | — | Filing → |